MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 35441-35450 Newer>
The Motley Fool
March 30, 2009
Toby Shute
An Enriching Nuclear Play? USEC is the only United States-based uranium player. But with outdated technology being employed at its one operating facility, and barbarians banging on the door, this company may be in danger. mark for My Articles 32 similar articles
The Motley Fool
March 30, 2009
Tim Beyers
Like I Said, Google Must Buy TiVo Google wants to improve how television ads are brokered by connecting its existing Google TV service -- think of it as AdWords for broadcasters -- to YouTube and other Web video sites. mark for My Articles 461 similar articles
The Motley Fool
March 30, 2009
Mike Pienciak
Drink In Diageo's Dividend Like a trusty bartender, you can count on spirits company Diageo to serve up a quality dividend. mark for My Articles 809 similar articles
The Motley Fool
March 30, 2009
David Lee Smith
Are BHP and Rio Tinto Courting Again? As Rio Tinto searches for debt repayment funds, BHP Billiton could re-enter the picture. mark for My Articles 304 similar articles
The Motley Fool
March 30, 2009
Anders Bylund
How to Settle Your Differences With Microsoft Privately held GPS navigation specialist TomTom can breathe a sigh of relief. The company has settled the patent infringement claims Microsoft brought against it. mark for My Articles 245 similar articles
The Motley Fool
March 30, 2009
Brian Orelli
Boston Scientific Is Abbott's Sweat Mop Abbott presented data from an ongoing head-to-head trial of Xience and competitor Boston Scientific's Taxus, and the results look even better than the earlier two-year data point. mark for My Articles 151 similar articles
The Motley Fool
March 30, 2009
Brian Orelli
Hopes Fall Short for Arena Pharmaceuticals Arena Pharmaceuticals' obesity drug lorcaserin doesn't look like it's doing enough to be a marketing success -- and the results might not even be enough to get it past the Food and Drug Administration. mark for My Articles 559 similar articles
The Motley Fool
March 30, 2009
2 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: American Ecology Corp... Doral Financial Corp. ... mark for My Articles 705 similar articles
The Motley Fool
March 30, 2009
Anders Bylund
Tech Stocks on the Rebound Let's find Nasdaq stragglers ready to come back with a vengeance. Take a look at: VASCO Data Security Intl. ... Silicon Image... Universal Display... mark for My Articles 113 similar articles
The Motley Fool
March 30, 2009
Anders Bylund
How 3-D Movies Will Save Theaters Since the Internet started nibbling away at Hollywood's traditional income streams, the movie industry has been trying to figure out how to entice people back into theaters. It looks like they've finally hit on a big audience-grabbing idea: 3-D movies. mark for My Articles 228 similar articles
<Older 35441-35450 Newer>    Return to current articles.